スポンサーリンク
Odagiri Norio | 論文著者
-
Odagiri Norio
Kashima Laboratory Mitsubishi Chemical Safety Institute
-
ODAGIRI NORIO
Kashima Laboratory, Mitsubishi Chemical Safety Institute
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mi
-
Odagiri Norio
Pharmacology Safety Assessment Group Nonclinical Research Center Drug Development Service Segment Mitsubishi Chemical Medience Co.
-
Odagiri Norio
Pharmacology Safety Assessment Group, Nonclinical Research Center, Drug Development Service Segment, Mitsubishi Chemical Medience Co.